 cisplatin combin chemotherapi elderli patient urotheli tumour proport cancer patient cur therapi declin chronolog age between januari januari patient year median combin chemotherapi eighteen patient cycl adjuv chemotherapi median drop creatinin clearanc rate ml/min ml/min patient aliv evid diseas whole group median surviv month dose intens cisplatin recurr eighteen patient metastat diseas object respons cycl median patient aliv free diseas group signific kidney damag dose intens cisplatin predict respons treatment signific sepsi rate patient withdrew treatment toxic cisplatin combin chemotherapi treatment-rel death efficaci similar patient age patient potenti benefit therapi import caus reduc benefit chemotherapi elderli patient reduc dosag cisplatin